EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metformin as a potential antidepressant: Mechanisms and therapeutic insights in depression

Yuan-Yuan Cheng, Qi Yao, Yang Miao, Wei Guan

Biochemical Pharmacology · 2025-03 · 233 · 116773

DOI: 10.1016/j.bcp.2025.116773 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2025-03. Verfasst von Yuan-Yuan Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Nantong Stomatological Hospital, Nantong 226001 Jiangsu, China. Hauptthemen laut MEDLINE: Metformin, Antidepressive Agents, Depression. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 124 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is one of the most disabling psychiatric disorders, whose pathophysiology has not been fully understood. Increasing numbers of preclinical studies have highlighted that metformin, as the first-line hypoglycaemic agent, has a potential pleiotropic effect on depression. Moreover, there is emerging evidence that metformin shows antidepressant activity and improves depressive symptoms in rodent models of depression. However, the exact role and underlying mechanism of metformin in depression remain unclear and still need to be investigated. Recent studies suggest that metformin not only improves neuronal damage and structural plasticity in the hippocampus but also enhances the antidepressant effect of antidepressants. Therefore, in this review, we summarize the existing evidence for the use of metformin as a psychopharmaceutical and elaborate on the underlying mechanisms of metformin in mitigating the onset and progression of depression, as well as the associated biochemical signaling pathways and targets involved in the pathogenesis of depression. After reviewing several studies, we conclude that metformin helps reduce depressive symptoms by targeting multiple pathways, including the regulation of neurotransmitters, enhanced neurogenesis, anti-inflammatory effects, and changes in gut microbiota. We aim to gain a deeper understanding of the mechanism of action of metformin and provide new insights into its clinical value in the prevention and therapy of depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminAntidepressive AgentsDepressionHumansAnimalsHypoglycemic AgentsHippocampus

Stichwörter der Autor:innen

AntidepressantsBDNFChronic stressDepressionMetforminNeurogenesis

Substanzen

MetforminAntidepressive AgentsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Nantong Stomatological Hospital, Nantong 226001 Jiangsu, China.
  • Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong 226001 Jiangsu, China.
  • Department of Pharmacology, The First People's Hospital of Yancheng, Yancheng 224000 Jiangsu, China. Electronic address: myang88508706@163.com.
  • Department of Pharmacology, Pharmacy College, Nantong University, Nantong 226001 Jiangsu, China. Electronic address: guanwei88@ntu.edu.cn.

Zitieren

APA

Cheng, Y. Y., Yao, Q., Miao, Y., & Guan, W. (2025). Metformin as a potential antidepressant: Mechanisms and therapeutic insights in depression. Biochemical Pharmacology, 233, 116773. https://doi.org/10.1016/j.bcp.2025.116773

Vancouver

Cheng YY, Yao Q, Miao Y, Guan W. Metformin as a potential antidepressant: Mechanisms and therapeutic insights in depression. Biochemical Pharmacology. 2025;233:116773. doi:10.1016/j.bcp.2025.116773

BibTeX
@article{Cheng2025,
  author = {Cheng, Yuan-Yuan and Yao, Qi and Miao, Yang and Guan, Wei},
  title = {Metformin as a potential antidepressant: Mechanisms and therapeutic insights in depression},
  journal = {Biochemical Pharmacology},
  year = {2025},
  volume = {233},
  pages = {116773},
  doi = {10.1016/j.bcp.2025.116773}
}
Kostenlos starten →